Patients with bladder urothelial carcinoma and thyroid carcinoma with upregulated FAT4 had a good prognosis (Fig. 8a,e), whereas patients with kidney renal clear cell carcinoma with downregulated FAT4 had a poor prognosis (Fig. 8m). This evidence concerns the gene FAT4 and bladder transitional cell carcinoma.